Quinoline Impurities: Reference Standards for a Core Pharmaceutical Building Block

Quinoline isn't a finished drug — it's something arguably more foundational: a heterocyclic aromatic building block used throughout pharmaceutical synthesis. Its ring structure forms the backbone of numerous active pharmaceutical ingredients and intermediates, which means impurity control at the quinoline level ripples downstream into the purity and safety of the final drug products built on it.

Why Quinoline Impurity Control Matters

Because quinoline and its derivatives feed into so many downstream synthesis pathways, even small variations in purity at this stage can carry through the manufacturing process. Regulatory bodies expect manufacturers working with quinoline-based intermediates to identify, quantify, and control:

  • Process-related impurities generated during synthesis
  • Degradation products formed during storage
  • Potential nitrosamine (N-NO) impurities, a focus area across current global regulatory guidance
  • Genotoxic impurities, requiring risk assessment even at trace levels

Reliable reference standards are the only way to confirm analytical methods are actually detecting and measuring these impurities accurately — rather than assuming a peak represents what it's labeled as.

What's in SynZeal's Quinoline Portfolio

SynZeal's Quinoline impurities and reference standards catalog covers the core molecule along with its key related compounds:

  • Quinoline (CAS 91-22-5) — the parent reference standard
  • 5-Hydroxyquinoline (CAS 578-67-6) — a hydroxylated derivative used in various synthesis routes
  • 7-Chloro-4-Phenoxyquinoline (CAS 124495-03-0) — a chlorinated intermediate relevant to several API syntheses
  • 3-Piperidinone Hydrochloride (CAS 61644-00-6) — a related building-block compound
  • Quinoline Impurity 1 (CAS 83-08-9) and Quinoline Impurity 2 (CAS 76915-95-2) — process-related impurities relevant to quality control programs

Each product is supplied with a detailed Certificate of Analysis (COA) and analytical data package meeting regulatory compliance expectations, with EP/USP-traceable standards available on request. Products are re-tested at regular intervals to support long-running QC and stability programs.

Where These Standards Fit in the Workflow

Quinoline-related reference standards are typically used across:

  1. ANDA and DMF filings — supplying the authentic impurity material regulators expect referenced in submission data
  2. Method development and validation — confirming analytical methods can reliably detect and quantify each known impurity
  3. Quality control (QC) testing — verifying batch purity at the intermediate or API stage
  4. Stability studies — tracking degradation behavior under various storage conditions
  5. Unknown impurity identification — matching unexpected peaks against known reference signatures
  6. Genotoxic impurity risk assessment — an increasingly standard requirement across regulatory filings

Explore the Full Catalog

Quinoline is one of hundreds of building blocks and APIs covered in SynZeal's broader portfolio of pharmaceutical reference standards, metabolites, nitrosamine impurities, and stable isotope-labelled compounds — backed by ISO 17025, ISO 17034, and ISO 9001 accreditation and an in-house cGMP manufacturing facility in Gujarat, India.

If your lab works with quinoline-based intermediates or APIs, it's worth browsing the full SynZeal product catalog for current stock status, or reaching out directly for compounds not yet listed.

This article is for general informational purposes and does not constitute regulatory or medical advice. These compounds are intended strictly for laboratory, research, and analytical use — not for human consumption. Product availability, CAS numbers, and specifications should always be verified directly on the manufacturer's website before ordering.

Comments

Post a Comment

Popular posts from this blog

The Crucial Role of Reference Standards in the Pharmaceutical Industry

Image
  Introduction In modern pharmaceutical research, accuracy isn’t optional—it’s essential. Every Active Pharmaceutical Ingredient (API) and every formulation depends on precise analytical testing. This is where reference standards play a critical role. These highly purified compounds serve as measurement benchmarks, ensuring that every analytical result is consistent, reliable, and compliant with global regulatory expectations. Among global providers, SynZeal Research has emerged as a trusted partner supplying high-quality impurity standards, reference standards, metabolites, and custom synthesis materials to support consistent analytical performance from R&D to regulatory submission. Why Reference Standards Matter in Pharma 1. Ensuring Accurate API Identification Pharmaceutical companies rely on reference standards to confirm the identity of APIs and impurities using techniques like HPLC, GC, LC-MS, NMR, and IR. A high-purity standard ensures that analytical teams can verify e...
Read more

Pharmaceutical Reference Standards: A Complete Guide by SynZeal

Image
  In modern pharmaceutical research and quality control, pharmaceutical reference standards are foundational tools that ensure accurate, consistent, and compliant analytical results. At SynZeal , we specialize in delivering high-purity reference materials — including APIs, impurity standards, metabolites, isotopically labelled compounds and custom reference standards — to support global drug development and regulatory testing workflows. What Are Pharmaceutical Reference Standards? A pharmaceutical reference standard is a well-characterized, highly purified material used as a benchmark for testing the identity, strength, quality, and purity of drug substances, excipients and finished products. These standards are essential in analytical method development, quality control testing, and regulatory submissions. Reference standards can be sourced from national or international pharmacopeias such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), or developed in-ho...
Read more

Impurity Reference Standards Across Therapeutic Areas: What Analytical Labs Need to Know

Image
  Impurity profiling looks different depending on which drug class you're testing. A diabetes drug, a statin, and an anticoagulant each carry their own set of process-related impurities, degradation products, and pharmacopeial (USP/EP) related compounds. Having the right, well-characterized reference standard for each is what actually makes a validated analytical method possible. Here's a practical look at three real examples spanning three major therapeutic categories — and why sourcing the correct reference standard matters more than it might seem. Quick Reference: The Three Impurities at a Glance Therapeutic Area Drug Impurity CAS No. Diabetes (SGLT2 inhibitor) Dapagliflozin Hydroxy Dapagliflozin (USP) 1204222-85-4 Cardiovascular (Statin) Pravastatin EP Impurity A (6′-Epipravastatin) 81176-41-2 Anticoagulant Dabigatran Etexilate Despyridyl Ethyl Ester 1408238-36-7 Diabetes: Dapagliflozin and Its Impurity Profile Dapagliflozin is an SGLT2 inhibitor widely used in ...
Read more